COMMUNIQUÉS West-GlobeNewswire

L'usine de médicaments stériles Curia nommée fabricant de l'année dans le Massachusetts
22/10/2025
ALBANY, N.Y., 22 oct. 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), une organisation leader dans la recherche, le développement et la fabrication sous contrat, a annoncé aujourd'hui que son usine de produits [...]
UFC® and Smith+Nephew announce multi-year extension of partnership
22/10/2025
Smith+Nephew to continue as UFC’s Preferred Sports Medicine Technology Partner Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and UFC the world’s premier mixed martial arts organization, have [...]
Fangzhou Unveils “AI + Weight Management” Innovation at China’s Inaugural National-Level Weight Management Symposium in Beijing
22/10/2025
BEIJING, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Healthy China: AI + Weight Management" Innovation Symposium was held at the National People's Congress Conference Center. The event was guided by the China Food and Drug [...]
Branded Legacy, Inc. (OTC: BLEG) Advances Life-Saving Innovation with FDA Pre-ANDA Briefing for Revolutionary Intranasal Naloxone Spray
22/10/2025
Pioneering Cost-Effective, Scalable Solutions to Combat the Global Opioid Crisis with Proprietary Air-Driven Delivery Technology VANCOUVER, British Columbia, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy, [...]
Nkarta Announces Poster Presentation at Upcoming American College of Rheumatology (ACR) Convergence Meeting
22/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune disease [...]
BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio
22/10/2025
MELVILLE, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and [...]
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
22/10/2025
Global employers can now empower their workforces with comprehensive women’s health benefits, supported by localized expertise NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader [...]
Akari Therapeutics Announces Launch of CEO Corner Platform
22/10/2025
CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested parties with the ability to ask questions and submit topics for future videos Access [...]
HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor “What This Means” Segment
22/10/2025
Watch the "What This Means" video here Featuring the Company’s pembrolizumab-based immune checkpoint inhibitor MIRAMAR, Fla., Oct. 22, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”), ( [...]
ADARx Pharmaceuticals Announces First Patient Dosed in Phase 3 STOP-HAE Clinical Trial and Orphan Drug Designation for ADX-324, a Long-Acting siRNA in Development for the Prophylactic Treatment of Hereditary Angioedema (HAE)
22/10/2025
– Next-generation siRNA therapeutic candidate with the potential for twice-yearly dosing – SAN DIEGO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company [...]
SELLAS Life Sciences to Participate in the J.P. Morgan U.S. Opportunities Forum
22/10/2025
Company to conduct 1x1 meetings with investors on Wednesday, November 12th NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical [...]
Femasys Announces Initiation of Post-Market Surveillance Study for FemBloc® Permanent Birth Control in Europe
22/10/2025
--Marks key milestone in European commercialization strategy under EU Medical Device Regulation (MDR)-- ATLANTA, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making [...]
Aeroflow Health Wins 2025 HME Provider of the Year Award
22/10/2025
Aeroflow Health's innovative approach to patient access, technology integration and partnership development sets a new standard for the home medical equipment industry ASHEVILLE, N.C. and CLEVELAND, Oct. 22, 2025 (GLOBE [...]
Wake-Up Call: Aeroflow Sleep Survey Reveals a Growing Gap in Sleep Health Education and the Rise of DIY Sleep Trends
22/10/2025
New survey of 1,884 adults finds 81% struggle with sleep while 60% try unvetted online trends without medical consultation ASHEVILLE, N.C., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Aeroflow Sleep, a national durable medical [...]
Fulcrum Therapeutics to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Wednesday, October 29, 2025, at 8:00 a.m. ET
22/10/2025
CAMBRIDGE, Mass., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
24/7 Market News- Kraig Labs Scalable Spider Silk May Unlock the Future of Lightweight Body Armor and Ballistic Protection
22/10/2025
DENVER, Oct. 22, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, believes that Kraig Biocraft Laboratories’ (OTCQB: [...]
Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe
22/10/2025
Initial target markets for commercialization include Germany, the Benelux countries, Austria, the United Kingdom, and Scandinavia Expands distributor channel coverage to ~35% of European Union population with ~300,000 [...]
Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) Stands Out with Proprietary Next-Gen Breast CT Imaging System
22/10/2025
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 70+ brands within [...]
Vivani Medical to Present at the ThinkEquity Conference on October 30, 2025
22/10/2025
ALAMEDA, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) (“Vivani” or the “Company”), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today [...]

Pages